Sp194

THE GENETIC EPIDEMIOLOGY OF PANCREATIC CANCER: RECENT INNOVATIONS IN AN EVOLVING LANDSCAPE

Date
May 6, 2023
Explore related products in the following collection:

Society: AGA

A translational symposium that focuses on the evolving role of artificial intelligence and machine learning in early detection of pancreatic cancer, genetic testing and novel molecular diagnostic bio-markers and recent advances in digital tools that can be applied to enhance early detection and improve care of high-risk individuals.

Presenter

Speaker Image for Elham Afghani
Johns Hopkins Hospital

Tracks

Related Products

Thumbnail for INCIDENCE OF EXOCRINE PANCREATIC INSUFFICIENCY AT 3 MONTHS AFTER ACUTE PANCREATITIS: A MULTICENTER PROSPECTIVE STUDY
INCIDENCE OF EXOCRINE PANCREATIC INSUFFICIENCY AT 3 MONTHS AFTER ACUTE PANCREATITIS: A MULTICENTER PROSPECTIVE STUDY
Background: The incidence of hypertriglyceridemia-associated acute pancreatitis (HTG-AP) has been increasing recently. Plasmapheresis can effectively remove triglyceride(TG) from plasma, but its clinical value in HTG-AP is unclear due to the lack of solid evidence…
Thumbnail for PLACEHOLDER
PLACEHOLDER
Perturbations in the gut mucosal immune response contributes to IBD. Non-immune cell popopulations including epithelial and stromal cells also play an important role in intestinal inflammation…
Thumbnail for PLACEHOLDER
PLACEHOLDER
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
Thumbnail for INTRODUCTION
INTRODUCTION
SOCIETY: AGA